查看购物车
  • Traditional Chinese
  • English
欧洲类器官服务市场报告（2021-2031）范围、细分、动态和竞争分析
市场调查报告书
商品编码
1843396

欧洲类器官服务市场报告（2021-2031）范围、细分、动态和竞争分析

Europe Organoids Services Market Report 2021-2031 by Scope, Segmentation, Dynamics, and Competitive Analysis
出版日期: | 出版商: The Insight Partners | 英文 136 Pages | 订单完成后即时交付

价格

预计欧洲类器官服务市场将大幅成长，到 2031 年将达到约 50.1603 亿美元，高于 2024 年的 12.3351 亿美元。这一成长代表着 2024 年至 2031 年的年复合成长率(CAGR) 为 22.2%。

执行摘要和市场分析

欧洲类器官服务市场主要分为几个主要区域，包括德国、法国、英国、西班牙、义大利和欧洲其他地区。该市场的成长受到多种因素的推动，包括组织工程和器官移植需求的不断增长，类器官在疾病建模、基因突变研究和肿瘤建模中的应用日益增多，以及针对类器官的研发活动激增。此外，公共和私营部门的资金和投资增加预计将在不久的将来为市场创造巨大的机会。

市场区隔分析

欧洲类器官服务市场可根据类型、应用和来源进行细分：

  • 依类型：市场分为各种器官类型，包括肠、肝、胃、胰臟、肺、脑、肾等。预计到2024年，肠道器官将占据最大的市场份额。
  • 依应用：类器官的应用分为发育生物学疾病、传染病病理学、再生医学、药物毒性和疗效测试、药物发现和个人化医疗等。预计发育生物学疾病领域将在2024年占据市场主导地位。
  • 依来源：市场也依类器官的来源细分，包括多能干细胞和器官特异性成体干细胞。预计到2024年，多能干细胞领域将占据更大的市场份额。

市场展望

欧洲对个人化医疗日益增长的需求是影响类器官技术发展和应用的重要因素，尤其是在肿瘤学和遗传性疾病领域。伦敦国王学院与葛兰素史克公司之间的一项重要合作体现了这一趋势，研究人员正在开发源自患者的肺癌类器官，以预测復发并确定有效的治疗组合。这些类器官旨在反映每位患者癌症中发现的独特基因突变，促进个人化治疗方案的选择。此外，欧洲药品管理局 (EMA) 已经认识到类器官技术在精准医疗中的重要性，并透过其自适应途径计划支持类器官等创新方法，以加快新疗法的审批，从而弥合研究与临床应用之间的差距。

国家洞察

欧洲类器官服务市场主要包括英国、法国、德国、西班牙、义大利及欧洲其他地区。预计德国将在2024年占据最大市场份额。

受组织工程和器官移植技术的进步以及持续进行的类器官研究的推动，德国对类器官服务的需求日益增长。德国蓬勃发展的研究部门正在推动新型类器官生成方法的出现，增强其在人类疾病建模中的作用，并开闢新的研究途径。得益于高品质的产品，德国生物技术产业展现出巨大的成长潜力。德国拥有众多专门从事类器官服务的公司，例如位于柏林的马克斯·德尔布吕克中心，该中心提供类器官衍生和表征的平台服务。

公司简介

欧洲类器官服务市场的主要参与者包括 CUSABIO TECHNOLOGY LLC、Cyprio、Eurofins Scientific SE、HUB Organoids BV（Hubrecht Organoid Technology）、InnoSer、InSphero、LABTOO、Molecular Devices, LLC、Oncodesign Services 和 Sino Biological Inc. 等。这些公司正在采用各种策略，包括扩张、产品创新和併购，以增强其产品服务并提升其市场占有率。

目录

第一章：简介

第 2 章：执行摘要

  • 关键见解

第三章：研究方法

  • 二次研究
  • 初步研究
    • 假设表述：
    • 宏观经济因素分析：
    • 显影基数：
    • 数据三角测量：
    • 国家级资料：

第四章：欧洲类器官服务市场格局

  • PEST分析

第五章：欧洲类器官服务市场－主要市场动态

  • 欧洲类器官服务市场－关键市场动态
  • 市场驱动因素
    • 创新药物筛选服务需求不断成长
    • 个人化药物的普及度激增
  • 市场限制
    • 缺乏熟练的专业人员
  • 市场机会
    • 增加关键发展
  • 未来趋势
    • 人工智慧的融合
  • 驱动因素和限制因素的影响：

第六章：欧洲类器官服务市场－分析

  • 2021-2031年欧洲类器官服务市场收入
  • 欧洲类器官服务市场预测分析

第七章：欧洲类器官服务市场分析－依类型

  • 肠
  • 肝
  • 胃
  • 胰臟
  • 肺
  • 脑
  • 肾
  • 其他的

第八章：欧洲类器官服务市场分析－依应用

  • 发育生物学疾病
  • 传染病病理学
  • 再生医学
  • 药物毒性和疗效测试
  • 药物研发与个人化医疗
  • 其他的

第九章：欧洲类器官服务市场分析－依来源

  • 多能干细胞
  • 器官特异性成体干细胞

第 10 章：欧洲类器官服务市场 - 国家分析

  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 欧洲其他地区

第 11 章：产业格局

  • 概述
  • 类器官服务市场的成长策略
  • 有机成长策略
    • 概述
  • 无机成长策略
    • 概述

第 12 章：公司简介

  • Sino Biological Inc.
  • Eurofins Scientific SE
  • Molecular Devices, LLC.
  • InSphero
  • Cyprio
  • InnoSer
  • LABTOO
  • CUSABIO TECHNOLOGY LLC
  • Oncodesign Services
  • HUB Organoids B.V. (Hubrecht Organoid Technology)

第 13 章：附录

Product Code: BMIRE00032024

The Europe organoids services market is projected to grow significantly, reaching approximately US$ 5,016.03 million by 2031, up from US$ 1,233.51 million in 2024. This growth represents a compound annual growth rate (CAGR) of 22.2% from 2024 to 2031.

Executive Summary and Market Analysis

The market for organoid services in Europe is divided into several key regions, including Germany, France, the UK, Spain, Italy, and the Rest of Europe. The growth in this market is driven by several factors, including the increasing demand for tissue engineering and organ transplantation, the rising use of organoids in disease modeling, gene mutation studies, and tumor modeling, as well as a surge in research and development focused on organoids. Additionally, enhanced funding and investments from both public and private sectors are expected to create substantial opportunities in the market in the near future.

Market Segmentation Analysis

The Europe organoids services market can be segmented based on type, application, and source:

  • By Type: The market is categorized into various organ types, including intestine, liver, stomach, pancreas, lung, brain, kidney, and others. In 2024, the intestine segment is anticipated to hold the largest market share.
  • By Application: The applications of organoids are segmented into developmental biology disease, pathology of infectious diseases, regenerative medicine, drug toxicity and efficacy testing, drug discovery and personalized medicine, among others. The developmental biology disease segment is expected to dominate the market in 2024.
  • By Source: The market is also segmented by the source of organoids, which includes pluripotent stem cells and organ-specific adult stem cells. The pluripotent stem cells segment is projected to have a larger market share in 2024.

Market Outlook

The increasing demand for personalized medicine in Europe is a significant factor influencing the advancement and application of organoid technologies, particularly in oncology and genetic disorders. A notable collaboration between King's College London and GSK exemplifies this trend, where researchers are developing patient-derived lung cancer organoids to predict relapse and identify effective treatment combinations. These organoids are designed to reflect the unique genetic mutations found in each patient's cancer, facilitating tailored therapy selection. Furthermore, the European Medicines Agency (EMA) has recognized the importance of organoid technology in precision medicine, supporting innovative methods like organoids through its adaptive pathways initiative to expedite the approval of new therapies, thus bridging the gap between research and clinical application.

Country Insights

The Europe organoids services market includes key countries such as the UK, France, Germany, Spain, Italy, and the Rest of Europe. Germany is expected to hold the largest market share in 2024.

The demand for organoid services in Germany is on the rise, driven by advancements in tissue engineering and organ transplantation, along with ongoing organoid research. The country's robust research sector is leading to the emergence of new organoid generation methods, enhancing their role in human disease modeling and opening new research avenues. Germany's biotechnology industry shows significant growth potential, supported by the high quality of its products. Numerous companies specializing in organoid services operate within the country, such as the Max Delbruck Center in Berlin, which provides platform services for organoid derivation and characterization.

Company Profiles

Key players in the Europe organoids services market include CUSABIO TECHNOLOGY LLC, Cyprio, Eurofins Scientific SE, HUB Organoids B.V. (Hubrecht Organoid Technology), InnoSer, InSphero, LABTOO, Molecular Devices, LLC, Oncodesign Services, and Sino Biological Inc., among others. These companies are employing various strategies, including expansion, product innovation, and mergers and acquisitions, to enhance their offerings and increase their market presence.

Table Of Contents

1. Introduction

  • 1.1 Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:

4. Europe Organoids Services Market Landscape

  • 4.1 PEST Analysis

5. Europe Organoids Services Market - Key Market Dynamics

  • 5.1 Europe Organoids Services Market - Key Market Dynamics
  • 5.2 Market Drivers
    • 5.2.1 Increasing Demand for Innovative Drug Screening Services
    • 5.2.2 Surge in Popularity of Personalized Drugs
  • 5.3 Market Restraints
    • 5.3.1 Dearth of Skilled Professionals
  • 5.4 Market Opportunities
    • 5.4.1 Increasing Key Developments
  • 5.5 Future Trends
    • 5.5.1 Integration of Artificial Intelligence
  • 5.6 Impact of Drivers and Restraints:

6. Europe Organoids Services Market - Analysis

  • 6.1 Europe Organoids Services Market Revenue (US$ Million), 2021-2031
  • 6.2 Europe Organoids Services Market Forecast Analysis

7. Europe Organoids Services Market Analysis - by Type

  • 7.1 Intestine
    • 7.1.1 Overview
    • 7.1.2 Intestine: Europe Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.2 Liver
    • 7.2.1 Overview
    • 7.2.2 Liver: Europe Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.3 Stomach
    • 7.3.1 Overview
    • 7.3.2 Stomach: Europe Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.4 Pancreas
    • 7.4.1 Overview
    • 7.4.2 Pancreas: Europe Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.5 Lung
    • 7.5.1 Overview
    • 7.5.2 Lung: Europe Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.6 Brain
    • 7.6.1 Overview
    • 7.6.2 Brain: Europe Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.7 Kidney
    • 7.7.1 Overview
    • 7.7.2 Kidney: Europe Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.8 Others
    • 7.8.1 Overview
    • 7.8.2 Others: Europe Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

8. Europe Organoids Services Market Analysis - by Application

  • 8.1 Developmental Biology Disease
    • 8.1.1 Overview
    • 8.1.2 Developmental Biology Disease: Europe Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.2 Pathology of Infectious Disease
    • 8.2.1 Overview
    • 8.2.2 Pathology of Infectious Disease: Europe Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.3 Regenerative Medicine
    • 8.3.1 Overview
    • 8.3.2 Regenerative Medicine: Europe Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.4 Drug Toxicity and Efficacy Testing
    • 8.4.1 Overview
    • 8.4.2 Drug Toxicity and Efficacy Testing: Europe Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.5 Drug Discovery and Personalized Medicine
    • 8.5.1 Overview
    • 8.5.2 Drug Discovery and Personalized Medicine: Europe Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.6 Others
    • 8.6.1 Overview
    • 8.6.2 Others: Europe Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

9. Europe Organoids Services Market Analysis - by Source

  • 9.1 Pluripotent Stem Cells
    • 9.1.1 Overview
    • 9.1.2 Pluripotent Stem Cells: Europe Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 9.2 Organ Specific Adult Stem Cell
    • 9.2.1 Overview
    • 9.2.2 Organ Specific Adult Stem Cell: Europe Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

10. Europe Organoids Services Market - Country Analysis

  • 10.1 Europe
    • 10.1.1 Europe Organoids Services Market - Revenue and Forecast Analysis - by Country
      • 10.1.1.1 Europe Organoids Services Market - Revenue and Forecast Analysis - by Country
      • 10.1.1.2 Germany: Europe Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.1.1.2.1 Germany: Europe Organoids Services Market Share - by Type
        • 10.1.1.2.2 Germany: Europe Organoids Services Market Share - by Application
        • 10.1.1.2.3 Germany: Europe Organoids Services Market Share - by Source
      • 10.1.1.3 United Kingdom: Europe Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.1.1.3.1 United Kingdom: Europe Organoids Services Market Share - by Type
        • 10.1.1.3.2 United Kingdom: Europe Organoids Services Market Share - by Application
        • 10.1.1.3.3 United Kingdom: Europe Organoids Services Market Share - by Source
      • 10.1.1.4 France: Europe Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.1.1.4.1 France: Europe Organoids Services Market Share - by Type
        • 10.1.1.4.2 France: Europe Organoids Services Market Share - by Application
        • 10.1.1.4.3 France: Europe Organoids Services Market Share - by Source
      • 10.1.1.5 Italy: Europe Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.1.1.5.1 Italy: Europe Organoids Services Market Share - by Type
        • 10.1.1.5.2 Italy: Europe Organoids Services Market Share - by Application
        • 10.1.1.5.3 Italy: Europe Organoids Services Market Share - by Source
      • 10.1.1.6 Spain: Europe Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.1.1.6.1 Spain: Europe Organoids Services Market Share - by Type
        • 10.1.1.6.2 Spain: Europe Organoids Services Market Share - by Application
        • 10.1.1.6.3 Spain: Europe Organoids Services Market Share - by Source
      • 10.1.1.7 Rest of Europe: Europe Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.1.1.7.1 Rest of Europe: Europe Organoids Services Market Share - by Type
        • 10.1.1.7.2 Rest of Europe: Europe Organoids Services Market Share - by Application
        • 10.1.1.7.3 Rest of Europe: Europe Organoids Services Market Share - by Source

11. Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in Organoids Services Market
  • 11.3 Organic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Inorganic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Sino Biological Inc.
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Eurofins Scientific SE
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Molecular Devices, LLC.
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 InSphero
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Cyprio
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 InnoSer
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 LABTOO
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 CUSABIO TECHNOLOGY LLC
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Oncodesign Services
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 HUB Organoids B.V. (Hubrecht Organoid Technology)
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments

13. Appendix

  • 13.1 About The Insight Partners
  • 13.2 Glossary of Terms

List Of Tables

  • Table 1. Europe Organoids Services Market Segmentation
  • Table 2. Europe Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Table 3. Europe Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Type
  • Table 4. Europe Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Application
  • Table 5. Europe Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Source
  • Table 6. Europe Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Country
  • Table 7. Germany: Europe Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
  • Table 8. Germany: Europe Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
  • Table 9. Germany: Europe Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source
  • Table 10. United Kingdom: Europe Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
  • Table 11. United Kingdom: Europe Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
  • Table 12. United Kingdom: Europe Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source
  • Table 13. France: Europe Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
  • Table 14. France: Europe Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
  • Table 15. France: Europe Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source
  • Table 16. Italy: Europe Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
  • Table 17. Italy: Europe Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
  • Table 18. Italy: Europe Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source
  • Table 19. Spain: Europe Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
  • Table 20. Spain: Europe Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
  • Table 21. Spain: Europe Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source
  • Table 22. Rest of Europe: Europe Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
  • Table 23. Rest of Europe: Europe Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
  • Table 24. Rest of Europe: Europe Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source
  • Table 25. Recent Organic Growth Strategies in Organoids Services Market
  • Table 26. Recent Inorganic Growth Strategies in the Organoids Services Market
  • Table 27. Glossary of Terms, Organoids Services Market

List Of Figures

  • Figure 1. Europe Organoids Services Market Segmentation - Country
  • Figure 2. PEST Analysis
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Europe Organoids Services Market Revenue (US$ Million), 2021-2031
  • Figure 5. Europe Organoids Services Market Share (%) - by Type (2023 and 2031)
  • Figure 6. Intestine: Europe Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 7. Liver: Europe Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 8. Stomach: Europe Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 9. Pancreas: Europe Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 10. Lung: Europe Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 11. Brain: Europe Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 12. Kidney: Europe Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 13. Others: Europe Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 14. Europe Organoids Services Market Share (%) - by Application (2023 and 2031)
  • Figure 15. Developmental Biology Disease: Europe Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 16. Pathology of Infectious Disease: Europe Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 17. Regenerative Medicine: Europe Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 18. Drug Toxicity and Efficacy Testing: Europe Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 19. Drug Discovery and Personalized Medicine: Europe Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 20. Others: Europe Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 21. Europe Organoids Services Market Share (%) - by Source (2023 and 2031)
  • Figure 22. Pluripotent Stem Cells: Europe Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 23. Organ Specific Adult Stem Cell: Europe Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 24. Europe Organoids Services Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 25. Germany: Europe Organoids Services Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 26. United Kingdom: Europe Organoids Services Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 27. France: Europe Organoids Services Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 28. Italy: Europe Organoids Services Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 29. Spain: Europe Organoids Services Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 30. Rest of Europe: Europe Organoids Services Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 31. Growth Strategies in Organoids Services Market